BridgeBio Pharma (BBIO) Change in Receivables (2024 - 2026)
BridgeBio Pharma (BBIO) reported Change in Receivables of $120.61 million for Q3 2026, up 204.2% from $39.65 million a year earlier and up 144.8% from the prior quarter.
Powered by 
Analysis
BridgeBio Pharma (BBIO) Change in Receivables (2024 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, BridgeBio Pharma's Change in Receivables came in at $258.57 million, up 122.8% year-over-year; for FY2025, it came in at $134.72 million.
- By year, Change in Receivables came in at $2.97 million in FY2024, -$15.33 million in FY2023 and -$15.17 million in FY2022.
- The Q3 2026 figure ranks as the highest quarterly Change in Receivables since Q1 2024.
- Year over year, Change in Receivables gained in two of the last four quarters, with growth averaging 137.8%.
- Per Business Quant data, the three quarters before Q3 2026 came in at $49.26 million (Q2 2026), $65.78 million (Q1 2026) and $22.93 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -188.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -312.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 108.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -52.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | BridgeBio Pharma | 15.42 Bn | 11.64 Bn | 332.72 Mn | 120.61 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 120.61 Mn |
| Jun 30, 2026 | 49.26 Mn |
| Mar 31, 2026 | 65.78 Mn |
| Dec 31, 2025 | 22.93 Mn |
| Sep 30, 2025 | 39.65 Mn |
| Jun 30, 2025 | -38.40 Mn |
| Mar 31, 2025 | 110.54 Mn |
| Dec 31, 2024 | 4.24 Mn |
| Sep 30, 2024 | -182,000.00 |
| Jun 30, 2024 | -234.83 Mn |
| Mar 31, 2024 | 233.74 Mn |
API Access
BridgeBio Pharma Change in Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-receivables&ticker=BBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-receivables", "ticker": "BBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-receivables&ticker=BBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();